MedTrace Logo

Bigfoot Biomedical Clinical Research Center (CRC) Trial

NCT02849288 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-12-19

No results posted yet for this study

Summary

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research Center (CRC) environment.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS)

Automated Insulin Delivery System

Sponsors & Collaborators

  • Jaeb Center for Health Research

    collaborator OTHER

  • Profil Institute for Clinical Research, Inc.

    collaborator OTHER

  • Bigfoot Biomedical Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02849288 on ClinicalTrials.gov